Stifel Downgrades InterMune; Roche Offer 'Appropriate Ending' By: Benzinga via Benzinga August 25, 2014 at 11:34 AM EDT Shares of InterMune (NASDAQ: ITMN) were downgraded to Hold from Buy by Stifel following Roche's proposed $8.3 billion acquisition ... Read More >>